Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Kolodner

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Psychiatric Clinics of North America|May 23, 2020
Update on the Neuropsychiatry of Substance Use DisordersGeorge Kolodner, Vassilis E Koliatsos
The Psychiatric Clinics of North America|September 2, 2022
Nicotine Addiction: A Burning Issue in Addiction PsychiatryGeorge Kolodner, Carlo C DiClemente, Michael M Miller
Journal of Addictive Diseases|February 16, 2010
Antidepressant-induced mania with concomitant mood stabilizer in patients with comorbid substance abuse and bipolar disorderDaniel Z Lieberman, George Kolodner, Suena H Massey, et al.
Journal of Addictive Diseases|January 13, 2016
Drug test results as a predictor of retention among patients using buprenorphine in a comprehensive outpatient treatment programMichael D Campbell, George Kolodner, Robert A Spencer, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Psychiatric Clinics of North America|May 23, 2020
Update on the Neuropsychiatry of Substance Use DisordersGeorge Kolodner, Vassilis E Koliatsos
The Psychiatric Clinics of North America|September 2, 2022
Nicotine Addiction: A Burning Issue in Addiction PsychiatryGeorge Kolodner, Carlo C DiClemente, Michael M Miller
Journal of Addictive Diseases|February 16, 2010
Antidepressant-induced mania with concomitant mood stabilizer in patients with comorbid substance abuse and bipolar disorderDaniel Z Lieberman, George Kolodner, Suena H Massey, et al.
Journal of Addictive Diseases|January 13, 2016
Drug test results as a predictor of retention among patients using buprenorphine in a comprehensive outpatient treatment programMichael D Campbell, George Kolodner, Robert A Spencer, et al.
Pageof 1